Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Cardiology
Published in: Pediatric Cardiology 5/2007

01-10-2007 | CASE REPORT

First Recanalization of a Coronary Artery Chronic Total Obstruction in an 11-Year-Old Child with Kawasaki Disease Sequelae Using the CROSSER Catheter

Authors: N. Dahdah, R. Ibrahim, L. Cannon

Published in: Pediatric Cardiology | Issue 5/2007

Login to get access

Abstract

This is a case of an 11½-year-old diagnosed with Kawasaki disease at 6 months of age. Distal left main coronary aneurysm involving the proximal anterior descending and circumflex had progressed into a chronic total occlusion. We report the first application of a novel percutaneous technique using the CROSSER catheter system in a child. The CROSSER is a high-frequency mechanical vibration catheter-based technology developed to safely penetrate through calcific and noncalcific coronary artery occlusions. This is also the first Kawasaki disease patient to benefit from this technology; in this disease, coronary artery stenosis is typically associated with heavy calcification.
Literature
1.
Akaji T, Ogawa S, Ino T, et al. (2000) Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation Group. J Pediatr 137:181–186CrossRef
2.
Buellesfeld L, Gerckens U, Mueller R, Schmidt T, Grube E (2005) Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry. Catheter Cardiovasc Interv 66:173–177CrossRefPubMed
3.
Colombo A, Drzewiecki J, Banning A, et al. TAXUS II Study Group (2003) Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel eluting stents for coronary artery lesion. Circulation 108:788–794CrossRefPubMed
4.
Grube E, Sütsch G, Lim VY, et al. (2006) High-frequency mechanical vibration to recanalize chronic total occlusions after failure to cross with conventional guidewires. J Invasive Cardiol 18:85–91PubMed
5.
Ishii M, Ueno T, Akagi T, et al. (2001) Research Committee of Ministry of Health, Labour and Welfare—“Study of treatment and long-term management in Kawasaki disease.” Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int 43: 558–562CrossRefPubMed
6.
Ishii M, Ueno T, Ikeda H, et al. (2002) Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 105:3004–3010CrossRefPubMed
7.
Kato H, Sugimura T, Akagi T, et al. (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385PubMed
8.
Kitamura S (2004) Advances in Kawasaki disease bypass surgery for coronary artery obstructions. Prog Pediatr Cardiol 19:167–177CrossRef
9.
Lapierre C, Dahdah NS, Guerin R, Fournier A, Miró J, Duret J-S (2002) Significance of coronary artery calcification in Kawasaki disease. 88th annual meeting, Radiology Society of North America, Chicago, IL, USA, December 2002. Radiology Suppl 225:134
10.
Li SS, Cheng BC, Lee SH (2005) Giant coronary aneurysm formation after sirolimus-eluting stent implantation in Kawasaki disease. Circulation 112:e105–e107CrossRefPubMed
11.
Melzi G, Cosgrave J, Biondi-Zoccai GL, et al. (2006) A novel approach to chronic total occlusions: the CROSSER system. Catheter Cardiovasc Interv 68:29–35CrossRefPubMed
12.
Migliorini A, Moschi G, Vergara R, et al. (2006) Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheter Cardiovasc Interv 67:344–348CrossRefPubMed
13.
Morice MC, Serruys PW, Sousa JE, et al. (2002) RAVEL Study Group. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780CrossRefPubMed
14.
Newburger JW, Takahashi M, Gerber MA, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease. A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Endorsed by the American Academy of Pediatrics. Circulation 10:2747–2771CrossRef
15.
Tanaka N, Naoe S, Masuda H, Veno T (1986) Pathological study of sequelae of Kawasaki disease MCLS: with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36:1513–1527PubMed
16.
Tsuda E, Kamiya T, Ono Y, et al. (2005) Incidence of stenotic lesions predicted by acute changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol 26:73–79CrossRefPubMed
17.
Tsuda E, Kitamura S, and the Cooperative Study Group of Japan (2004) National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 110(Suppl 1):II61–II66PubMed
Metadata
Title
First Recanalization of a Coronary Artery Chronic Total Obstruction in an 11-Year-Old Child with Kawasaki Disease Sequelae Using the CROSSER Catheter
Authors
N. Dahdah
R. Ibrahim
L. Cannon
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 5/2007
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-006-0083-3

Other articles of this Issue 5/2007

Pediatric Cardiology 5/2007 Go to the issue

OriginalPaper

Long-Term Behavior and Quality of Life After Corrective Cardiac Surgery in Infancy for Tetralogy of Fallot or Ventricular Septal Defect

CASE REPORT

Conditions Mimicking Coarctation of the Aorta

CASE REPORT

Swallow Syncope Associated with Complete Atrioventricular Block in an Adolescent

ORIGINAL ARTICLE

Gene Polymorphisms of TNF-α−308, IL-10−1082, IL-6−174, and IL-1RaVNTR Related to Susceptibility and Severity of Rheumatic Heart Disease

ORIGINAL ARTICLE

Symptoms of Dysautonomia, Sleep Disturbance, and Abnormal Cognition in Pediatric Heart Failure

CASE REPORT

Quadrivalvar Replacement in Infantile Marfan Syndrome

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits